Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 09:43 am Purchase |
2023-12-31 | 13G | Janux Therapeutics, Inc. JANX |
BIOTECHNOLOGY VALUE FUND L P | 4,579,818 9.900% |
472,873 (+11.51%) |
Filing History |
| 2024-02-14 09:41 am Sale |
2023-12-31 | 13G | Jasper Therapeutics, Inc. JSPR |
BIOTECHNOLOGY VALUE FUND L P | 0 0.000% |
-990,000 (Position Closed) |
Filing History |
| 2024-02-14 09:39 am Purchase |
2023-12-31 | 13G | Kura Oncology, Inc. KURA |
BIOTECHNOLOGY VALUE FUND L P | 7,373,228 9.900% |
3,572,245 (+93.98%) |
Filing History |
| 2024-02-14 09:37 am Purchase |
2023-12-31 | 13G | Lexicon Pharmaceuticals, Inc. LXRX |
BIOTECHNOLOGY VALUE FUND L P | 24,435,632 9.980% |
8,286,453 (+51.31%) |
Filing History |
| 2024-02-14 09:35 am Sale |
2023-12-31 | 13G | Merus N.V. MRUS |
BIOTECHNOLOGY VALUE FUND L P | 2,752,420 4.800% |
-226,000 (-7.59%) |
Filing History |
| 2024-02-14 09:33 am Purchase |
2023-12-31 | 13G | Molecular Templates, Inc. MTEM |
BIOTECHNOLOGY VALUE FUND L P | 537,426 9.990% |
537,426 (New Position) |
Filing History |
| 2024-02-14 09:31 am Purchase |
2023-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
BIOTECHNOLOGY VALUE FUND L P | 5,763,948 9.990% |
738,048 (+14.68%) |
Filing History |
| 2024-02-14 09:28 am Sale |
2023-12-31 | 13G | Pyxis Oncology, Inc. PYXS |
BIOTECHNOLOGY VALUE FUND L P | 0 0.000% |
-2,938,851 (Position Closed) |
Filing History |
| 2024-02-14 09:26 am Sale |
2023-12-31 | 13G | Revolution Medicines, Inc. RVMD |
BIOTECHNOLOGY VALUE FUND L P | 5,981,212 3.600% |
-1,574,376 (-20.84%) |
Filing History |
| 2024-02-14 09:24 am Purchase |
2023-12-31 | 13G | Tyra Biosciences, Inc. TYRA |
BIOTECHNOLOGY VALUE FUND L P | 2,739,595 6.400% |
267,268 (+10.81%) |
Filing History |
| 2024-02-14 09:22 am Sale |
2023-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
BIOTECHNOLOGY VALUE FUND L P | 0 0.000% |
-2,302,094 (Position Closed) |
Filing History |
| 2024-02-14 09:20 am Purchase |
2023-12-31 | 13G | Verastem, Inc. VSTM |
BIOTECHNOLOGY VALUE FUND L P | 2,617,402 9.990% |
2,617,402 (New Position) |
Filing History |
| 2024-01-29 5:13 pm Sale |
2024-01-25 | 13D | Rain Enhancement Technologies Holdco Inc RAIN |
BIOTECHNOLOGY VALUE FUND L P | 0 0.000% |
-3,526,729 (Position Closed) |
Filing History |
| 2024-01-29 4:31 pm Unchanged |
2023-03-29 | 13G | GlycoMimetics, Inc. GLYC |
BIOTECHNOLOGY VALUE FUND L P | 9,544,262 14.800% |
0 (Unchanged) |
Filing History |
| 2024-01-18 4:32 pm Purchase |
2024-01-16 | 13G | Allakos Inc. ALLK |
BIOTECHNOLOGY VALUE FUND L P | 16,552,417 18.900% |
8,000,000 (+93.54%) |
Filing History |
| 2024-01-18 4:29 pm Purchase |
2023-12-31 | 13G | Allakos Inc. ALLK |
BIOTECHNOLOGY VALUE FUND L P | 8,552,417 9.800% |
3,545,496 (+70.81%) |
Filing History |
| 2024-01-18 4:18 pm Purchase |
2024-01-08 | 13G | Immunic, Inc. IMUX |
BIOTECHNOLOGY VALUE FUND L P | 8,902,972 9.900% |
8,902,972 (New Position) |
Filing History |
| 2024-01-16 5:22 pm Purchase |
2024-01-11 | 13D | XOMA Corporation XOMA |
BIOTECHNOLOGY VALUE FUND L P | 3,633,743 31.600% |
103,200 (+2.92%) |
Filing History |
| 2024-01-09 4:45 pm Purchase |
2024-01-05 | 13D | Kymera Therapeutics, Inc. KYMR |
BIOTECHNOLOGY VALUE FUND L P | 5,831,171 9.990% |
1,138,567 (+24.26%) |
Filing History |
| 2023-12-20 4:38 pm Sale |
2023-12-18 | 13D | POINT Biopharma Global Inc. PNT |
BIOTECHNOLOGY VALUE FUND L P | 0 0.000% |
-17,437,375 (Position Closed) |
Filing History |